Ruichu Medicine is a biopharmaceutical company focusing on the research and development of First-in-class. It was co-founded by a team with 30 years of new drug R&D management in the US and China industries and years of accumulation of cutting-edge science and technology. The company focuses on new science and technology, and is committed to the treatment of a variety of major degenerative diseases, including neurodegenerative diseases, fibrotic diseases, and inflammatory diseases. Recently, Ruichu Medicine completed an angel round of financing, led by Dynamic Balance Capital, followed by Jinyu Bogor and Nanjing Innovation Investment Group. This round of financing will be used for the clinical application and development of core projects, and to promote the early R&D and layout of multiple aging pipelines.
This article is transferred from: https://www.itjuzi.com/investevent/13619906
This site is only for collection, and the copyright belongs to the original author.